AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 37679687 — intervention group
Group type: EXPERIMENTAL
Intervention: Particle-depleted diesel exhaust (PDDE)
Number of subjects: 13
Study 37679687 — intervention group
Group type: COMPARATOR
Intervention: Filtered air (FA)
Number of subjects: 13
Study 37679687 — intervention group
Group type: COMPARATOR
Intervention: Diesel exhaust (DE)
Number of subjects: 13
Study 37679712 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote monitoring intervention for managing heart failure, including tracking patients' weight and diuretic adherence.
Number of subjects: 43
Study 37679712 — intervention group
Group type: EXPERIMENTAL
Intervention: Lottery intervention as part of the remote monitoring program.
Number of subjects: 43
Study 37679712 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic alerts as part of the remote monitoring intervention.
Number of subjects: 43
Study 37679723 — intervention group
Group type: EXPERIMENTAL
Intervention: CGRP infusion (1.5 µg/min) over 20 min
Number of subjects: 34
Study 37679760 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic patients
Number of subjects: 11714
Study 37679760 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic patients with HPR phenotype
Number of subjects: 11714
Study 37679771 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrospective collection of EQ-5D-5L
Number of subjects: 676
Study 37679771 — intervention group
Group type: COMPARATOR
Intervention: Standard prospective collection of EQ-5D-5L
Number of subjects: 676
Study 37679845 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual motivational interviewing sessions (online or in-person) with a trained interviewer plus educational materials (based on Canada's food guide and physical activity recommendations)
Number of subjects: 0
Study 37679845 — intervention group
Group type: COMPARATOR
Intervention: Educational materials only
Number of subjects: 0
Study 37679845 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual motivational interviewing sessions (online or in-person) with a trained interviewer plus educational materials
Number of subjects: 0
Study 37680714 — intervention group
Group type: EXPERIMENTAL
Intervention: Aficamten
Number of subjects: 0
Study 37680714 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 37680774 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiorespiratory fitness assessment
Number of subjects: 0
Study 37680774 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study 37680791 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 639
Study 37680791 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 639
Study 37680795 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-cytokine treatment (tocilizumab in 53 patients, anakinra in 27 patients)
Number of subjects: 167
Study 37680795 — intervention group
Group type: COMPARATOR
Intervention: No anti-cytokine treatment (77 patients)
Number of subjects: 167
Study 37680795 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-cytokine treatment
Number of subjects: 167
Study 37680795 — intervention group
Group type: EXPERIMENTAL
Intervention: CMV reactivation
Number of subjects: 167
Study 37680815 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially threaded cannulated screw fixation (cancellous screws 6 mm)
Number of subjects: 82
Study 37680815 — intervention group
Group type: COMPARATOR
Intervention: Fully threaded cannulated screw fixation (cancellous screws 6 mm)
Number of subjects: 82
Study 37680892 — intervention group
Group type: EXPERIMENTAL
Intervention: Osilodrostat
Number of subjects: 60
Study 37680942 — intervention group
Group type: EXPERIMENTAL
Intervention: CT017 CAR T cells at a dose of 250 × 10^6
Number of subjects: 6
Study 37680953 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous stem cell transplantation (ASCT)
Number of subjects: 407
Study 37680953 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic MRD monitoring among ASCT
Number of subjects: 407
Study 37681206 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated addiction team follow-up
Number of subjects: 611
Study 37681206 — intervention group
Group type: COMPARATOR
Intervention: Control group (no addiction monitoring)
Number of subjects: 611
Study 37681235 — intervention group
Group type: EXPERIMENTAL
Intervention: Washed microbiota transplantation (WMT)
Number of subjects: 54
Study 37681568 — intervention group
Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid plus docosahexaenoic acid (3.36 g/d) for 30 months
Number of subjects: 240
Study 37681568 — intervention group
Group type: COMPARATOR
Intervention: None (control group)
Number of subjects: 240
Study 37681996 — intervention group
Group type: EXPERIMENTAL
Intervention: ICE-guided CBA (Group B)
Number of subjects: 1906
Study 37681996 — intervention group
Group type: COMPARATOR
Intervention: Conventional CBA (Group A)
Number of subjects: 1906
Study 37681996 — intervention group
Group type: COMPARATOR
Intervention: Non-ICE usage
Number of subjects: 1906
Study 37682079 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-hypnosis and self-care group intervention
Number of subjects: 95
Study 37682253 — intervention group
Group type: EXPERIMENTAL
Intervention: Odor stimulation with breast milk (BM)
Number of subjects: 32
Study 37682253 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 32
Study 37682255 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body Dual-energy X-ray absorptiometry (DXA) to assess skeletal muscle mass
Number of subjects: 30
Study 37682255 — intervention group
Group type: EXPERIMENTAL
Intervention: Handgrip dynamometer to measure muscle strength adjusted to body mass index
Number of subjects: 30
Study 37682255 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthropometric data collection including age, sex, body mass index, disease duration, and therapeutic management
Number of subjects: 30
Study 37682255 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison to age and sex reference curves
Number of subjects: 30
Study 37682255 — intervention group
Group type: EXPERIMENTAL
Intervention: DXA scans for body composition including appendicular lean mass and skeletal muscle mass
Number of subjects: 30
Study 37682297 — intervention group
Group type: EXPERIMENTAL
Intervention: Coach-guided video-conferencing expressive writing program
Number of subjects: 0
Study 37682297 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 37682405 — intervention group
Group type: EXPERIMENTAL
Intervention: IND 75 µg
Number of subjects: 80
Study 37682405 — intervention group
Group type: EXPERIMENTAL
Intervention: IND 150 µg
Number of subjects: 80
Study 37682406 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivermead Post-Concussion Symptoms Questionnaire (RPQ) - Dutch
Number of subjects: 2054
Study 37682406 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivermead Post-Concussion Symptoms Questionnaire (RPQ) - English
Number of subjects: 2054
Study 37682406 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivermead Post-Concussion Symptoms Questionnaire (RPQ) - Finnish
Number of subjects: 2054
Study 37682406 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivermead Post-Concussion Symptoms Questionnaire (RPQ) - Italian
Number of subjects: 2054
Study 37682406 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivermead Post-Concussion Symptoms Questionnaire (RPQ) - Norwegian
Number of subjects: 2054
Study 37682406 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivermead Post-Concussion Symptoms Questionnaire (RPQ) - Spanish
Number of subjects: 2054
Study 37682573 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive treatment with varenicline
Number of subjects: 188
Study 37682573 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment with varenicline
Number of subjects: 188
Study 37682573 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive treatment with nicotine patches
Number of subjects: 188
Study 37682573 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment with nicotine patches
Number of subjects: 188
Study 37682593 — intervention group
Group type: EXPERIMENTAL
Intervention: SyMon-SAYS intervention (16 weeks)
Number of subjects: 200
Study 37682593 — intervention group
Group type: COMPARATOR
Intervention: Usual care (8 weeks) followed by SyMon-SAYS intervention (8 weeks)
Number of subjects: 200
Study 37682601 — intervention group
Group type: EXPERIMENTAL
Intervention: 68Ga-LNC1007 PET/CT
Number of subjects: 61
Study 37682601 — intervention group
Group type: COMPARATOR
Intervention: 2-18F-FDG PET/CT
Number of subjects: 61
Study 37682601 — intervention group
Group type: COMPARATOR
Intervention: 68Ga-FAPI-02 PET/CT
Number of subjects: 61
Study 37682601 — intervention group
Group type: EXPERIMENTAL
Intervention: 68Ga-LNC1007 PET
Number of subjects: 61
Study 37682613 — intervention group
Group type: EXPERIMENTAL
Intervention: PETFL/MRI
Number of subjects: 34
Study 37682613 — intervention group
Group type: COMPARATOR
Intervention: mpMRI
Number of subjects: 34
Study 37682613 — intervention group
Group type: COMPARATOR
Intervention: PET/MRI PROMISE
Number of subjects: 34
Study 37682791 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenalidomide plus rituximab (LR)
Number of subjects: 36
Study 37682792 — intervention group
Group type: EXPERIMENTAL
Intervention: Zanubrutinib (160 mg twice daily)
Number of subjects: 68
Study 37682839 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity respiratory muscle training (60% of MIP and MEP)
Number of subjects: 34
Study 37682839 — intervention group
Group type: COMPARATOR
Intervention: Sham training (0cmH2O)
Number of subjects: 34
Study 37682839 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity respiratory muscle training
Number of subjects: 34
Study 37682839 — intervention group
Group type: COMPARATOR
Intervention: Sham training
Number of subjects: 34
Study 37682841 — intervention group
Group type: EXPERIMENTAL
Intervention: Implicit learning intervention delivered by clinical teams, requiring therapists to change instructions and feedback during rehabilitation.
Number of subjects: 39
Study 37682841 — intervention group
Group type: EXPERIMENTAL
Intervention: Implicit learning intervention
Number of subjects: 39
Study 37682841 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of the implicit learning intervention
Number of subjects: 39
Study 37682841 — intervention group
Group type: EXPERIMENTAL
Intervention: Teams with a flexible culture
Number of subjects: 39
Study 37682887 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic paste (CTZ)
Number of subjects: 120
Study 37682887 — intervention group
Group type: COMPARATOR
Intervention: Iodoform paste (Guedes-Pinto)
Number of subjects: 120
Study 37682920 — intervention group
Group type: EXPERIMENTAL
Intervention: Ablative fractional CO2 laser treatment
Number of subjects: 60
Study 37682920 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 60
Study 37682953 — intervention group
Group type: EXPERIMENTAL
Intervention: Abemaciclib pre-operatively for 4.5 days at twice daily dosing
Number of subjects: 7
Study 37682953 — intervention group
Group type: EXPERIMENTAL
Intervention: Abemaciclib therapy along with temozolomide
Number of subjects: 7
Study 37682971 — intervention group
Group type: EXPERIMENTAL
Intervention: PopART intervention (arms A and B combined)
Number of subjects: 1750
Study 37682971 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care (arm C)
Number of subjects: 1750
Study 37682971 — intervention group
Group type: EXPERIMENTAL
Intervention: People living with HIV
Number of subjects: 1750
Study 37682971 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-negative individuals
Number of subjects: 1750
Study 37683037 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant pembrolizumab (anti-PD-1), 2 doses
Number of subjects: 0
Study 37683048 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-profile double plating (one superiorly positioned VariAx 2.0mm and one anterior VariAx 2.4mm or 2.7mm plate)
Number of subjects: 336
Study 37683048 — intervention group
Group type: COMPARATOR
Intervention: Single plating (standard locally available implant)
Number of subjects: 336
Study 37683048 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-profile double plating
Number of subjects: 336
Study 37683048 — intervention group
Group type: COMPARATOR
Intervention: Single plating
Number of subjects: 336
Study 37683047 — intervention group
Group type: EXPERIMENTAL
Intervention: PlaySmart digital health game
Number of subjects: 532
Study 37683047 — intervention group
Group type: COMPARATOR
Intervention: Time/attention control videogames
Number of subjects: 532
Study 37683098 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-Term Oxygen Therapy (LTOT)
Number of subjects: 0
Study 37683098 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 0
Study 37683122 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment strategies for pulmonary exacerbations in pediatric cystic fibrosis patients
Number of subjects: 0
Study 37683122 — intervention group
Group type: COMPARATOR
Intervention: Control group (if applicable)
Number of subjects: 0
Study 37683234 — intervention group
Group type: EXPERIMENTAL
Intervention: Brexpiprazole Combination Therapy
Number of subjects: 1
Study 37683234 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 1
Study 37683276 — intervention group
Group type: EXPERIMENTAL
Intervention: FF-10850
Number of subjects: 0
Study 37683276 — intervention group
Group type: EXPERIMENTAL
Intervention: FF-10850 + anti-PD-1 antibody
Number of subjects: 0
Study 37683518 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin therapy plus standard care
Number of subjects: 5160
Study 37683518 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 5160
Study 37683686 — intervention group
Group type: EXPERIMENTAL
Intervention: upadacitinib 15 mg once daily
Number of subjects: 681
Study 37683686 — intervention group
Group type: EXPERIMENTAL
Intervention: upadacitinib 30 mg once daily
Number of subjects: 681
Study 37683686 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 681
Study 37683799 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 M True Definition Intraoral Scanner or 3 M Lava Chairside Oral Scanner
Number of subjects: 55
Study 37683799 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D Wear Analysis (3DWA)-protocol with Geomagic Qualify
Number of subjects: 55
Study 37683799 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 55
Study 37683823 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac transplantation
Number of subjects: 311
Study 37684058 — intervention group
Group type: EXPERIMENTAL
Intervention: MISTIE intervention (minimally invasive surgery + recombinant tissue plasminogen activator (rt-PA))
Number of subjects: 506
Study 37684058 — intervention group
Group type: COMPARATOR
Intervention: Standard medical care
Number of subjects: 506
Study 37684252 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab + nab-paclitaxel
Number of subjects: 52
Study 37684267 — intervention group
Group type: EXPERIMENTAL
Intervention: Free-floating video laryngoscopy at the head of the manikin
Number of subjects: 0
Study 37684267 — intervention group
Group type: COMPARATOR
Intervention: Conventional direct laryngoscopy in an ice-pick position
Number of subjects: 0
Study 37684282 — intervention group
Group type: EXPERIMENTAL
Intervention: Permutation-based inference and a new ranked-based test statistic to identify sex-based epigenetic differences.
Number of subjects: 0
Study 37684332 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal-spraying Bacillus spores (LiveSpo Navax) containing 5 billion of Bacillus subtilis and B. clausii spores in 5 mL.
Number of subjects: 0
Study 37684332 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal-spraying Bacillus spores (LiveSpo Navax)
Number of subjects: 0
Study 37684373 — intervention group
Group type: EXPERIMENTAL
Intervention: TRC105 monotherapy (10 mg/kg)
Number of subjects: 22
Study 37684373 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab+TRC105
Number of subjects: 22
Study 37684426 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic seeds (MS) placed into the target lymph node (TLN) before NACT
Number of subjects: 187
Study 37684485 — intervention group
Group type: EXPERIMENTAL
Intervention: MMTT glucose AUC (180-min)
Number of subjects: 168
Study 37684485 — intervention group
Group type: EXPERIMENTAL
Intervention: MMTT glucose AUC (240-min)
Number of subjects: 168
Study 37684485 — intervention group
Group type: EXPERIMENTAL
Intervention: MMTT glucose iAUC (180-min)
Number of subjects: 168
Study 37684485 — intervention group
Group type: EXPERIMENTAL
Intervention: MMTT insulin AUC (180-min)
Number of subjects: 168
Study 37684485 — intervention group
Group type: EXPERIMENTAL
Intervention: MMTT insulin AUC (240-min)
Number of subjects: 168
Study 37684485 — intervention group
Group type: EXPERIMENTAL
Intervention: MMTT insulin iAUC (180-min)
Number of subjects: 168
Study 37684485 — intervention group
Group type: COMPARATOR
Intervention: Fasting OGTT glucose
Number of subjects: 168
Study 37684485 — intervention group
Group type: COMPARATOR
Intervention: 120-min OGTT glucose
Number of subjects: 168
Study 37684485 — intervention group
Group type: COMPARATOR
Intervention: OGTT insulin AUC and iAUC
Number of subjects: 168
Study 37684526 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with Metabolic syndrome (MetS)
Number of subjects: 229
Study 37684526 — intervention group
Group type: COMPARATOR
Intervention: Patients without Metabolic syndrome (MetS)
Number of subjects: 229
Study 37684597 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength exercise
Number of subjects: 168
Study 37684597 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (stationary cycling)
Number of subjects: 168
Study 37684597 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 168
Study 37684597 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength exercise and Aerobic exercise
Number of subjects: 168
Study 37684648 — intervention group
Group type: EXPERIMENTAL
Intervention: Retromuscular synthetic mesh during closure of loop ileostomy
Number of subjects: 0
Study 37684648 — intervention group
Group type: COMPARATOR
Intervention: Standard suture closure of the abdominal wall
Number of subjects: 0
Study 37684648 — intervention group
Group type: EXPERIMENTAL
Intervention: Retromuscular synthetic mesh
Number of subjects: 0
Study 37684648 — intervention group
Group type: COMPARATOR
Intervention: Standard care (suture closure)
Number of subjects: 0
Study 37684682 — intervention group
Group type: EXPERIMENTAL
Intervention: Link work intervention (treatment as usual plus a link worker intervention) consisting of six sessions over 9 months.
Number of subjects: 84
Study 37684682 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control).
Number of subjects: 84
Study 37684688 — intervention group
Group type: EXPERIMENTAL
Intervention: MDM with ADBoard (Arm A: MDM-AB)
Number of subjects: 0
Study 37684688 — intervention group
Group type: COMPARATOR
Intervention: Conventional MDM (Arm B: MDM-C)
Number of subjects: 0
Study 37684697 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS-CPN with bupivacaine
Number of subjects: 0
Study 37684697 — intervention group
Group type: COMPARATOR
Intervention: EUS-CPN without bupivacaine
Number of subjects: 0
Study 37684728 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-CABG depression
Number of subjects: 161
Study 37685793 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive transthoracic echocardiographic assessment including strain and myocardial work analysis of the left and right heart chambers within 48 hours of admission after coronary angiography.
Number of subjects: 0
Study 37685793 — intervention group
Group type: EXPERIMENTAL
Intervention: Laboratory profile focusing on systemic inflammation captured during the first 24 hours upon admission.
Number of subjects: 0
Study 37685793 — intervention group
Group type: EXPERIMENTAL
Intervention: Documentation of angioplasty details and non-culprit coronary lesions, and evaluation of coronary artery disease complexity using the SYNTAX score.
Number of subjects: 0
Study 37685793 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-month follow-up period for all patients recruited.
Number of subjects: 0
Study 37685975 — intervention group
Group type: EXPERIMENTAL
Intervention: Citrus and pomegranate complex (CPC) 500 mg
Number of subjects: 36
Study 37685975 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 37685992 — intervention group
Group type: EXPERIMENTAL
Intervention: IMMAX (comprehensive immune age index)
Number of subjects: 1605
Study 37685992 — intervention group
Group type: EXPERIMENTAL
Intervention: EYOL (equivalent years of life)
Number of subjects: 1605
Study 37685992 — intervention group
Group type: EXPERIMENTAL
Intervention: IMMAX centiles
Number of subjects: 1605
Study 37685992 — intervention group
Group type: EXPERIMENTAL
Intervention: Age gap (difference between EYOL and chronological age)
Number of subjects: 1605
Study 37685992 — intervention group
Group type: EXPERIMENTAL
Intervention: Sex
Number of subjects: 1605
Study 37686032 — intervention group
Group type: EXPERIMENTAL
Intervention: Runcaciguat 1 mg/kg/bid
Number of subjects: 0
Study 37686032 — intervention group
Group type: EXPERIMENTAL
Intervention: Runcaciguat 3 mg/kg/bid
Number of subjects: 0
Study 37686032 — intervention group
Group type: EXPERIMENTAL
Intervention: Runcaciguat 10 mg/kg/bid
Number of subjects: 0
Study 37686032 — intervention group
Group type: EXPERIMENTAL
Intervention: Runcaciguat
Number of subjects: 0
Study 37686032 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 37686537 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant radiochemotherapy
Number of subjects: 0
Study 37686537 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant study concept
Number of subjects: 0
Study 37688515 — intervention group
Group type: EXPERIMENTAL
Intervention: Kiosk
Number of subjects: 482
Study 37688515 — intervention group
Group type: COMPARATOR
Intervention: Clinic
Number of subjects: 482
Study 37688515 — intervention group
Group type: COMPARATOR
Intervention: Home
Number of subjects: 482
Study 37688515 — intervention group
Group type: EXPERIMENTAL
Intervention: New hypertension diagnosis
Number of subjects: 482
Study 37688515 — intervention group
Group type: COMPARATOR
Intervention: No new hypertension diagnosis
Number of subjects: 482
Study 37688515 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 482
Study 37689018 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose (60 Gy) IMRT with weekly cisplatin
Number of subjects: 88
Study 37689244 — intervention group
Group type: EXPERIMENTAL
Intervention: Naïve FGF21
Number of subjects: 442